Investigation Reports Quality Assurance (QA SOP) INVESTIGATION REPORT FOR THE OBSERVATION OF ORANGE PEEL EFFECT OBSERVED DURING THE IN-PROCESS CHECK AT COATING STAGE Background: On 15/02/2026, during routine in-process inspection at the coating stage, tablets were visually… PharmaGuide HubMarch 5, 2026No comments
Investigation Reports Quality Assurance (QA SOP) INVESTIGATION REPORT FOR REFRIGERATOR DAILY TEMPERATURE MONITORING RECORD WAS NOT AVAILABLE As per GMP requirements and company SOPs, refrigerators used for pharmaceutical raw materials, intermediates,… PharmaGuide HubJanuary 10, 2026No comments
Investigation Reports Quality Assurance (QA SOP) INVESTIGATION REPORT FOR PRODUCT MIXUP During routine in-process blister inspection on 05/12/2025, one red-coloured Methylcobalamin 1500 mcg tablet was… PharmaGuide HubDecember 5, 2025No comments
Investigation Reports Quality Assurance (QA SOP) INVESTIGATION REPORT FOR THE OBSERVATION OF DOUBLE TABLET PACKED IN A SINGLE BLISTER POCKET DURING PRIMARY PACKING During in-process blister inspection on 04/12/2025, one pocket was observed to contain two tablets. The line was… PharmaGuide HubDecember 4, 2025No comments
Investigation Reports Quality Assurance (QA SOP) INVESTIGATION REPORT FOR THE OBSERVATION OF BATCH RECORD ENTRIES THAT WERE NOT FILLED ONLINE During an internal audit conducted on 27/11/2025, it was observed that: • Activities for granulation and… PharmaGuide HubNovember 28, 2025No comments
HOLD TIME STUDY Quality Assurance (QA SOP) HOLD TIME STUDY PROTOCOL CUM REPORT FOR DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HCL CHLORPHENIRAMINE MALEATE SYRUP Hold time – The established time period for which dispensed raw materials, intermediates (in-process materials)… PharmaGuide HubNovember 25, 2025No comments
HOLD TIME STUDY Quality Assurance (QA SOP) HOLD TIME STUDY PROTOCOL CUM REPORT FOR ITRACONAZOLE CAPSULE 100 mg Hold time – The established time period for which dispensed raw materials, intermediates (in-process materials)… PharmaGuide HubNovember 24, 2025No comments
PRODUCT DEVELOPMENT REPORT (PDR) Quality Assurance (QA SOP) Pharmaceutical Development report for the Ursodeoxycholic Acid Tablets BP 300 mg A Product Development Report (PDR) for Ursodeoxycholic Acid 300 mg Tablets is a comprehensive technical document… PharmaGuide HubNovember 22, 2025No comments
HOLD TIME STUDY Quality Assurance (QA SOP) HOLD TIME STUDY PROTOCOL CUM REPORT FOR ACECLOFENAC PARACETAMOL & SERRATIOPEPTIDASE TABLETS The established time period for which dispensed raw materials, intermediates (in-process materials) and bulk… PharmaGuide HubNovember 18, 2025No comments
Investigation Reports Quality Assurance (QA SOP) INVESTIGATION REPORT FOR THE OBSERVATION OF SMALLER SHIPPER THAN STANDARD SIZE During routine in-process inspection at the secondary packaging area on 03/11/2025, it was observed that one set… PharmaGuide HubNovember 3, 2025No comments